Azzad Asset Management’s Dentsply Sirona XRAY Stock Holding History

Azzad Asset Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,712	Closed	-$367K	–	326
2018 Q3	$367K	Sell	9,712 -60	-0.6%	-$2.5K	0.1%	276
2018 Q2	$428K	Buy	9,772 +3,796	+64%	+$178K	0.12%	253
2018 Q1	$301K	Buy	5,976 +233	+4%	+$13.7K	0.09%	274
2017 Q4	$378K	Buy	5,743 +308	+6%	+$19.6K	0.12%	236
2017 Q3	$325K	Buy	5,435 +210	+4%	+$12.5K	0.11%	252
2017 Q2	$339K	Sell	5,225 -15,221	-74%	-$962K	0.12%	243
2017 Q1	$1.28M	Sell	20,446 -1,127	-5%	-$67.8K	0.48%	67
2016 Q4	$1.25M	Sell	21,573 -82	-0.4%	-$4.84K	0.51%	66
2016 Q3	$1.29M	Sell	21,655 -135	-0.6%	-$8.29K	0.53%	64
2016 Q2	$1.35M	Buy	21,790 +83	+0.4%	+$5.11K	0.58%	51
2016 Q1	$1.34M	Buy	+21,707	New	+$1.28M	0.58%	44

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Azzad Asset Management's XRAY Position: Q4 2018 in Review

Azzad Asset Management sold out of Dentsply Sirona (XRAY) in Q4 2018, closing a stake of 9,712 shares — an estimated $367K sold.

Azzad Asset Management first reported a position in XRAY in Q1 2016 and held it in 11 quarters. The position peaked at $1.35M in Q2 2016. 495 funds tracked by Wall St. Rank hold XRAY as of Q4 2018.

Azzad Asset Management reported no remaining Dentsply Sirona position as of Q4 2018 after selling out during the quarter.
Azzad Asset Management sold 9,712 Dentsply Sirona shares in Q4 2018, an estimated $367K.
Azzad Asset Management first reported a position in Dentsply Sirona in Q1 2016 and held it in 11 quarters.
Azzad Asset Management's Dentsply Sirona position peaked at $1.35M in Q2 2016.
495 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2018.

Based on Azzad Asset Management's 13F filing for Q4 2018, filed 1 Apr 2024.